Diversified Healthcare Trust (DHC) - Stock Analysis

Last updated: Apr 11, 2026

Real EstateClosed

Research Idea

Research content for general circulation. Not individualized advice. Methodology & Disclosures

Highly speculative but event-driven: upcoming Q4 release and call (2/23–24), active asset sales earmarked to fully repay 2026 bonds, and SHOP operator transitions create a near-term binary setup where confirmation of proceeds and leverage reduction could trigger a sharp relief rally from depressed levels.

Loading chart data...

Idea window: 2/19/2026 – 2/26/2026Sector: Real Estate

AI Analyst Overview

Last Price
$7.13
Market Cap
$1.73B
1D Return
-2.19%
YTD Return
+47.31%

Loading chart data...

Valuation Metrics

P/E
-6.0
P/B
1.0
P/S
1.1
EV/EBITDA
24.4
Div Yield
0.56%

Fundamental Analysis

7.0

Key Financial Insights: • Strong FCF • High leverage • Persistent losses DHC shows strong free-cash-flow and improving operating margins but remains unprofitable with high leverage and heavy capex that pressure net income and solvency.

Improving
Leverage

Price Behavior

6.0

Key Price Behavior Insights: • Mild downtrend • Tested support • Resistance cap Support Level: $6.62–$6.71 Resistance Level: $7.30–$7.42 Over the last month DHC has drifted mildly lower from $7.42 to $7.13, finding support around $6.62–$6.71 but repeatedly capped by resistance near $7.30–$7.42, producing choppy ~11% intramonth swings that require a breakout above $7.30–$7.42 to confirm a trend reversal.

bearish
watch

Sentiment & News

6.0

Key News Insights: • Rising short interest • Token distribution • Earnings ahead DHC faces rising short interest (up 20.6% to ~3.5% of shares) amid a token $0.01 quarterly distribution and ahead of Q1 results due May 4–5.

bearish
watchlist
AI

AI Summary

6.0
Neutral

DHC has shifted from a likely restructuring to an execution-dependent turnaround after asset sales removed near‑term maturities, so investors should take an opportunistic stance contingent on timely dispositions and sustained SHOP NOI/RevPOR gains. Monitor disposition timing/receipts, net debt/EBITDA reduction, and quarter‑over‑quarter NOI/FCF durability—misses would rapidly re‑introduce refinancing risk and compress the current deep P/TBV discount.

Turnaround
ExecutionRisk
Leverage
AI summary updated 1 days ago

Description

DHC is a real estate investment trust that holds a portfolio of properties across the United States serving medical, life-science, senior-living and wellness uses. Its operations are run by the operating subsidiary of The RMR Group Inc., an alternative asset management company based in Newton, Massachusetts.

Idea History

DateCloseTickerCompanySummaryStatusP/L
Feb 19Feb 26DHCDiversified Healthcare Trust
Highly speculative but event-driven: upcoming Q4 release and call (2/23–24), active asset sales earmarked to fully repay 2026 bonds, and SHOP operator transitions create a near-term binary setup where confirmation of proceeds and leverage reduction could trigger a sharp relief rally from depressed levels.
Closed+7.1%
Research content for educational purposes only. Not investment advice. All decisions are your responsibility.